Literature DB >> 15158945

Poly-epsilon-caprolactone microspheres and nanospheres: an overview.

V R Sinha1, K Bansal, R Kaushik, R Kumria, A Trehan.   

Abstract

Poly-epsilon-caprolactone (PCL) is a biodegradable, biocompatible and semicrystalline polymer having a very low glass transition temperature. Due to its slow degradation, PCL is ideally suitable for long-term delivery extending over a period of more than one year. This has led to its application in the preparation of different delivery systems in the form of microspheres, nanospheres and implants. Various categories of drugs have been encapsulated in PCL for targeted drug delivery and for controlled drug release. Microspheres of PCL either alone or of PCL copolymers have been prepared to obtain the drug release characteristics. This article reviews the advancements made in PCL-based microspheres and nanospheres with special reference to the method of preparation of these and their suitability in developing effective delivery systems. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158945     DOI: 10.1016/j.ijpharm.2004.01.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  113 in total

1.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

2.  Bioresorbable Vesicles Formed through Spontaneous Self-Assembly of Amphiphilic Poly(ethylene oxide)-block-polycaprolactone.

Authors:  P Peter Ghoroghchian; Guizhi Li; Dalia H Levine; Kevin P Davis; Frank S Bates; Daniel A Hammer; Michael J Therien
Journal:  Macromolecules       Date:  2006-03-07       Impact factor: 5.985

3.  Design of Micelle Nanocontainers Based on PDMAEMA-b-PCL-b-PDMAEMA Triblock Copolymers for the Encapsulation of Amphotericin B.

Authors:  Ivonne L Diaz; Claudia Parra; Melva Linarez; Leon D Perez
Journal:  AAPS PharmSciTech       Date:  2015-02-11       Impact factor: 3.246

Review 4.  Recent developments in cyclic acetal biomaterials for tissue engineering applications.

Authors:  Erin E Falco; Minal Patel; John P Fisher
Journal:  Pharm Res       Date:  2008-06-07       Impact factor: 4.200

5.  Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.

Authors:  Maite Estevan; Carlos Gamazo; Fernando Martínez-Galan; Juan M Irache
Journal:  AAPS PharmSciTech       Date:  2008-10-16       Impact factor: 3.246

Review 6.  Biocompatible Polymers Combined with Cyclodextrins: Fascinating Materials for Drug Delivery Applications.

Authors:  Bartłomiej Kost; Marek Brzeziński; Marta Socka; Małgorzata Baśko; Tadeusz Biela
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

7.  Mechanical properties of a new thermally deformable mitral valve annuloplasty ring and its effects on the mitral valve.

Authors:  Tatsuya Seki; Katsuyoshi Jimuro; Yasushige Shingu; Satoru Wakasa; Hiroki Katoh; Tomonori Ooka; Tsuyoshi Tachibana; Suguru Kubota; Toshiro Ohashi; Yoshiro Matsui
Journal:  J Artif Organs       Date:  2018-11-19       Impact factor: 1.731

8.  Polymeric implants for the delivery of green tea polyphenols.

Authors:  Pengxiao Cao; Jeyaprakash Jeyabalan; Farrukh Aqil; Srivani Ravoori; Ramesh C Gupta; Manicka V Vadhanam
Journal:  J Pharm Sci       Date:  2014-01-24       Impact factor: 3.534

Review 9.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

10.  Formulation, and Evaluation of Pentoxifylline-Loaded Poly(epsilon-caprolactone) Microspheres.

Authors:  S Tamizharasi; J C Rathi; V Rathi
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.